Results 31 to 40 of about 6,588,446 (248)

Association of elevated inflammatory markers and severe COVID-19

Medicine, 2020
Our study aimed to assess the existing evidence on whether severe coronavirus disease 2019 (COVID-19) is associated with elevated inflammatory markers.
Pan Ji, Jie-Yun Zhu, Zhimei Zhong, Hong-Yuan Li, Jie-Long Pang, Bocheng Li, Jian-Feng Zhang   +6 more
semanticscholar   +1 more source

Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? [PDF]

, 2009
<p><b>Background:</b> Circulating inflammatory markers may more strongly relate to risk of fatal versus nonfatal cardiovascular disease (CVD) events, but robust prospective evidence is lacking.
Jukema, J.W., Westendorp, R.G.J., Lowe, G.D., Murray, H.M., Cobbe, S., de Craen, A.J.M., Blauw, G.J., Ford, I., Welsh, P.I., Murphy, M.B., Buckley, B.M., Macfarlane, P.W., Stott, D.J., Sattar, N.A., Shepherd, J., Gerard J Blauw, Chris J Packard, Ian Ford, Ford Ian, David J Stott, Sattar Naveed, Welsh Paul, Stuart Cobbe, Westendorp Rudi G. J., Lowe Gordon D., Heather M Murray, Paul Welsh, Murphy Michael B., Macfarlane Peter W., Peter W Macfarlane, James Shepherd, Buckley Brendan M., Stott David J., Cobbe Stuart, Jukema J. Wouter, J Wouter Jukema, Murray Heather M., Anton J M de Craen, de Craen Anton J. M., Packard Chris J., Naveed Sattar, Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Study Group, Blauw Gerard J., Brendan M Buckley, Michael B Murphy, Rudi G J Westendorp, Gordon D Lowe, Shepherd James, Packard, Chris J, Westendorp, Rudi G J, Blauw, Gerard J, de Craen, Anton J M, Welsh, Paul, Ford, Ian, Murray, Heather M, Stott, David J, Lowe, Gordon D, Jukema, J Wouter, Murphy, Michael B, Macfarlane, Peter W, Shepherd, James, Sattar, Naveed, Cobbe, Stuart, Buckley, Brendan M   +63 more
core   +3 more sources

Socioeconomic inequalities in coronary heart disease risk in older age: contribution of established and novel coronary risk factors [PDF]

, 2009
Background: Evidence on socioeconomic inequalities in coronary heart disease (CHD) and their pathways in the elderly is limited. Little is also known about the contributions that novel coronary risk factors (particularly inflammatory/hemostatic markers ...
Morris, RW, R. W. MORRIS, Whincup, PH, Papacosta, O, Lennon, L., G. LOWE, O. PAPACOSTA, Lowe, G., Rumley, A., A. RUMLEY, S. G. WANNAMETHEE, Whincup, P. H., Ramsay, S. E., Wannamethee, SG, Morris, R. W., P. H. WHINCUP, Lowe, G.D., Papacosta, O., Wannamethee, S. G., S. E. RAMSAY, Ramsay, SE, Rumley, A, Lennon, L, L. LENNON, Lowe, G   +24 more
core   +1 more source

Calprotectin in rheumatic diseases: a review

Rheumatology, 2016
Calprotectin also known as MRP8/14 or S100A8/A9 is a heterodimeric complex of two S100 calcium-binding proteins: myeloid-related protein 8 (MRP-8 or S100A8) and MRP-14 (or S100A9). At present, according to many authors, it is considered that calprotectin
Magdalena Kopeć-Mędrek, Małgorzata Widuchowska, Eugeniusz J. Kucharz   +2 more
doaj   +1 more source

Maternal inflammatory, lipid and metabolic markers and associations with birth and breastfeeding outcomes

Frontiers in Nutrition, 2023
BackgroundConditions in utero influence intrauterine and postnatal infant growth and a few studies indicate that maternal inflammation and insulin resistance might affect birth and breastfeeding outcomes.
Sophie Hilario Christensen, Ane Lilleøre Rom, Ane Lilleøre Rom, Tine Greve, Jack Ivor Lewis, Hanne Frøkiær, Lindsay H. Allen, Christian Mølgaard, Kristina Martha Renault, Kristina Martha Renault, Kim F. Michaelsen   +10 more
doaj   +1 more source

Arginase and Procalcitonin: Promising Biomarkers for Early Diagnosis of Sepsis [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Sepsis remains a major cause of death in critically ill patients in Indian population because of high susceptibility towards infectious diseases in the world. Procalcitonin (PCT) is a well-studied marker in foreign countries but needs to
Shruti Rahul Mulgund, Subodhini Anant Abhang   +1 more
doaj   +1 more source

The effect of inflammatory markers on the CORADS degree and the effects of treatments on RT-PCR test results in COVID-19 [PDF]

, 2022
Objective: There is still no diagnosis method with high sensitivity and specificity for COVID-19. Patient complaints, real-time reverse transcription-polymerase chain reaction (RT-PCR), inflammatory markers, clinical prognosis, and the degree of ...
Özge Alkan Tali, Berrin Yalınbaş Kaya, Hatice Hamarat, Rabiye Altınbaş, Aral Karabağ   +4 more
core   +2 more sources

Utility of serological markers in inflammatory bowel diseases: Gadget or magic? [PDF]

, 2007
The panel of serologic markers for inflammatory bowel diseases (IBD) is rapidly expanding. Although anti-Saccharomyces cerevisiae antibodies (ASCA) and atypical perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) remain the most widely ...
Papp, Mária, Lakatos, Péter László, Norman, G. L., Altorjay, István   +3 more
core   +1 more source

Associations of proinflammatory cytokines with the risk of recurrent stroke [PDF]

, 2008
<p><b>Background and Purpose:</b> There are few reports on proinflammatory cytokines and risk of primary or recurrent stroke. We studied the association of interleukin (IL)-6, IL-18, and tumor necrosis factor-α (TNF-α) with recurrent ...
Welsh, P., Chalmers, J., Lowe, G.D., Neal, B.C., MacMahon, S.W., Rumley, A., Campbell, D., Woodward, M.   +7 more
core   +1 more source

The impact of adjuvant atorvastatin therapy on community-acquired pneumonia outcome: a prospective study of clinical and inflammatory responses in relation to mortality reduction

The Egyptian Journal of Bronchology, 2019
Introduction In treatment of pneumonia, new drugs besides antibiotics are investigated; especially statins with their anti-inflammatory, immunomodulatory, and antioxidant effects.
Yasser M. Mohamed, Ashraf M. Madkour, Rehab M. Mohammed, Mohamed G. El-Shiekh   +3 more
doaj   +1 more source